Meeting
2021 Genitourinary Cancers Symposium
Long-term survival outcomes of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: A systematic review and individual patient data meta-analysis.
Authors
Stepan M. Esagian
Oncology Working Group, Society of Junior Doctors, Athens, Greece
Stepan M. Esagian , Ioannis A. Ziogas , Dimitrios Kosmidis , Mohammad D. Hossain , Nizar M. Tannir , Pavlos Msaouel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 317)
DOI
10.1200/JCO.2021.39.6_suppl.317
Abstract #
317
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients.
First Author: Dimitrios Makrakis
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival outcomes of metastatic renal cell carcinoma (mRCC) with sarcomatoid differentiation (SD): A single-institutional experience and literature meta-analysis.
First Author: Esmail Mutahar Al-Ezzi
Poster
2017 Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy in elderly patients with metastatic renal cell carcinoma in an era of targeted therapy.
First Author: Dipesh Uprety
Poster
2024 ASCO Genitourinary Cancers Symposium
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with immunotherapy: A systematic review and meta-analysis.
First Author: Fengnian Zhao